rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
10
|
pubmed:dateCreated |
1999-2-3
|
pubmed:abstractText |
Staging of Hodgkin's disease (HD) is accomplished by a variety of invasive and non-invasive modalities. This prospective study was undertaken to investigate the value of whole-body positron emission tomography (PET) with 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) in defining regions involved by lymphoma compared with conventional staging methods in patients with HD.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0923-7534
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1117-22
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9834825-Adolescent,
pubmed-meshheading:9834825-Adult,
pubmed-meshheading:9834825-Aged,
pubmed-meshheading:9834825-Child,
pubmed-meshheading:9834825-False Negative Reactions,
pubmed-meshheading:9834825-False Positive Reactions,
pubmed-meshheading:9834825-Female,
pubmed-meshheading:9834825-Fluorodeoxyglucose F18,
pubmed-meshheading:9834825-Hodgkin Disease,
pubmed-meshheading:9834825-Humans,
pubmed-meshheading:9834825-Magnetic Resonance Imaging,
pubmed-meshheading:9834825-Male,
pubmed-meshheading:9834825-Middle Aged,
pubmed-meshheading:9834825-Neoplasm Staging,
pubmed-meshheading:9834825-Prospective Studies,
pubmed-meshheading:9834825-Radiopharmaceuticals,
pubmed-meshheading:9834825-Tomography, Emission-Computed,
pubmed-meshheading:9834825-Tomography, X-Ray Computed
|
pubmed:year |
1998
|
pubmed:articleTitle |
Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin's disease.
|
pubmed:affiliation |
Department of Medicine III (Hematology, Oncology, Clinical Immunology and Infectious Diseases), University of Ulm, Germany.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|